We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Review of Egrifta Delayed by FDA
Advisory Committee Review of Egrifta Delayed by FDA
January 29, 2010
The FDA has delayed a Feb. 24 FDA advisory committee meeting for Theratechnologies’ Egrifta for administrative reasons, according to the company.